Google has invested in Navigenics, hoping to broaden its reach to include genetic information, say this Business Week article. As the media sees it, Navigenics is hoping to pull away from 23andMe (which Google also invested in). "23andMe has taken the approach of providing you a fun, social, and ancestral look at your DNA," says Amy DuRoss, head of policy and business affairs for Navigenics, whereas her company "has taken the v

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.